CA
NZ
UK
AU
IND
US
Novartis Capital Corporation filed a free writing prospectus on November 9, 2026, disclosing pricing terms for a four-tranche U.S. dollar-denominated notes offering totaling $5,250,000,000, fully and unconditionally guaranteed by Novartis AG.
JATT II Acquisition Corp. filed a definitive proxy statement and prospectus on November 9, 2026, asking shareholders to approve a business combination with Talawar Tx Inc. under a Business Combination Agreement dated June 29, 2026.
Reviva Pharmaceuticals Holdings, Inc. filed a definitive proxy statement on November 9, 2026, calling stockholders to vote on five proposals at an annual meeting scheduled for December 18, 2026, including a potential reverse stock split at a ratio ranging from 1:2 to 1:100.
NeoVolta, Inc. filed a Definitive Proxy Statement on November 9, 2026, notifying stockholders of a 2026 Annual Meeting to be held December 22, 2026, at the company's offices in Poway, California, to vote on director elections, auditor ratification, a new stock plan, and an …
Fly-E Group, Inc. filed Definitive Additional Materials (DEFA14A) on November 9, 2026, supplementing its October 29, 2026 proxy statement to postpone the Special Meeting of Stockholders from November 13 to November 27, 2026, and to clarify and expand disclosure around a proposed securities offering.
NeoVolta, Inc. filed Definitive Additional Proxy Materials on November 9, 2026, notifying shareholders of five proposals to be voted on at the company's Annual Meeting scheduled for December 22, 2026.
Wintergreen Acquisition Corp. filed a definitive proxy statement on November 9, 2026, calling an Extraordinary General Meeting for November 30, 2026, to seek shareholder approval to extend the company's Business Combination deadline from May 28, 2027 to May 28, 2028, and to eliminate any …
Reviva Pharmaceuticals Holdings, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission on November 9, 2026, disclosing share count, market capitalization, and company classification details.
CKX Lands, Inc. filed soliciting material under Schedule 14A on November 9, 2026, consisting of a transcript of a conference call in which Brad Jacobs announced a $1 billion investment in CKX Lands and outlined progress at QXO.
W. R. Berkley Corporation and its subsidiary Berkley Insurance Company filed a Schedule 13G on November 9, 2026, disclosing beneficial ownership of ordinary shares in Flag Ship Acquisition Corporation as of September 30, 2026.
Please wait processing your request...